Literature DB >> 7009003

Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.

R J Sung, H L Waxman, B Elser, Z Juma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7009003

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN： 0147-958X            Impact factor:   0.825


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers.

Authors:  D N John; S Fort; M J Lewis; D K Luscombe
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

Review 2.  Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?

Authors:  H O Klein; E Kaplinsky
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

3.  Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter.

Authors:  S Fort; M J Lewis; D K Luscombe; D N John
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

Review 4.  Calcium antagonists. Clinical use in the treatment of arrhythmias.

Authors:  B N Singh; K Nademanee; S H Baky
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.